Leukocytosis and the Retinoic Acid Syndrome in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide
- 1 July 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (13) , 2620-2625
- https://doi.org/10.1200/jco.2000.18.13.2620
Abstract
PURPOSE: Arsenic trioxide, like all-trans-retinoic acid (RA), induces differentiation of acute promyelocytic leukemia (APL) cells in vivo. Treatment of APL patients with all-trans RA is commonly as...Keywords
This publication has 39 references indexed in Scilit:
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4British Journal of Haematology, 1996
- Leucocyte-endothelial interactions and regulation of leucocyte migrationThe Lancet, 1994
- Treatment of acute promyelocytic leukemia with all‐trans retinoic acid: Successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyureaAmerican Journal of Hematology, 1993
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- Retinoic acid syndromeThe Lancet, 1993
- Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groupsThe Lancet, 1993
- Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8Science, 1991
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991